Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment.
Rickles
F R
FR
Department of Medicine, University of Connecticut School of Medicine, Farmington 06032.
Hancock
W W
WW
Edwards
R L
RL
Zacharski
L R
LR
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001777:Blood Coagulation; D005337:Fibrin / Q000502:physiology*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000473:pathology* / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D005337:Fibrin